Clinical Trial Update: Study to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure [Phase 2]

View source ↗

Summary

Clinical Trial Update reports the completion of a Phase 2 study evaluating alovudine for antiviral activity and safety in nucleoside-experienced HIV-infected su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Alovudine (alovudine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: COMPLETED